Valinor Discovery

Valinor Discovery is a biotechnology company that leverages generative machine learning and proprietary, patient-matched longitudinal multi-omics datasets to simulate therapeutic performance. By creating virtual patient profiles, the company aims to de-risk clinical drug development, reduce trial-and-error, and accelerate breakthroughs across various therapeutic areas, with an initial focus on oncology and neurology. The company operates as a technology-enabled platform for drug developers, providing custom models trained on primary cell and clinical assay data. Valinor collaborates with academic institutions and sequencing companies to establish industry benchmarks for perturbation prediction models and to generate high-resolution molecular datasets to support large foundation model development.